The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: erythromycin     Quarter: 2016Q3

Total Records: 166     Number of Pages: 9

DRUGNAME PT EventCount
ERYTHROMYCIN. Lyme disease 2
ERYTHROMYCIN. Product use issue 2
ERYTHROMYCIN. Tachycardia 2
ERYTHROMYCIN. Throat tightness 2
ERYTHROMYCIN ESTOLATE. Drug intolerance 1
ERYTHROMYCIN ESTOLATE. Hypersensitivity 1
ERYTHROMYCIN ESTOLATE. Infection 1
ERYTHROMYCIN ESTOLATE. International normalised ratio fluctuation 1
ERYTHROMYCIN ETHYLSUCCINATE. Drug hypersensitivity 1
ERYTHROMYCIN LACTOBIONATE Liver injury 1
ERYTHROMYCIN LACTOBIONATE Urticaria 1
ERYTHROMYCIN OPHTHALMIC OINTMENT 0.5%, USP Application site pain 1
Erythromycin Ophthalmic Ointment 0.5%, USP Corneal abrasion 1
Erythromycin Ophthalmic Ointment 0.5%, USP Drug ineffective 1
ERYTHROMYCIN OPHTHALMIC OINTMENT 0.5%, USP Eye irritation 1
ERYTHROMYCIN OPHTHALMIC OINTMENT 0.5%, USP Eye pruritus 1
ERYTHROMYCIN OPHTHALMIC OINTMENT 0.5%, USP Eyelids pruritus 1
ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Condition aggravated 1
ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Drug ineffective 1
ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Eye discharge 1

Total Records: 166     Number of Pages: 9